Sugammadex vs Placebo to Prevent Residual Neuromuscular Block
Clinical trial NCT02728726 · COMPLETED
Trial details
- NCT number
- NCT02728726
- Sponsor
- Mayo Clinic
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2019-12-01
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.